Autologous bone marrow mononuclear cells transplantation in treatment of severe lower limb ischemia in 56 cases in the same institute: One-year follow up

Wang Wei,Liu Chang-jian,Qiao Tong,Liu Chen,Huang Dian
DOI: https://doi.org/10.3969/j.issn.1673-8225.2010.45.036
2010-01-01
Abstract:BACKGROUND:Autologous bone marrow mononuclear cell transplantation for treatment of lower limb ischemia has obtained satisfactory short-term curative effects,but lacks of long-term follow up.In particular,few reports have addressed peripheral artery disease patients with severe lower limb ischemia.OBJECTIVE:To investigate the efficacy of autologous bone marrow mononuclear cells transplantation in treatment of severe lower limb ischemia in 4 weeks and 1 year follow up.METHODS:From January 2005 to January 2009,56 patients(59 limbs) with severe lower limb ischemia were treated.300 mL bone marrow blood was extracted from patients' ilium to separate and prepare autologous bone marrow mononuclear cells.The transplant part was from occlusion site of middle and lower extremity artery trunk.According to the way of arterial ambulation,stem cell suspension was made and injected once every 1.0-2.0 cm(each 1 mL).The local transplantation of lower limb ischemia muscle was performed.All patients received cell transplantation only once.The amount of transplanted bone marrow mononuclear cells was(0.31-29.46)×109(mean 10.93×109).RESULTS AND CONCLUSION:All patients were followed up for one year.After 4 weeks of implantation,the results of visual analogue scale,maximum walking distance,ankle brachial index,TcPO2 were superior at 4 weeks and 1 year following surgery compared with the preoperative results(P < 0.05).After one year of implantation,angiography revealed 28.8%(17/59) effective rate.No related complication was observed in patients after transplantation.
What problem does this paper attempt to address?